Cargando…

Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients

BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoochehri, Mehdi, Hielscher, Thomas, Borhani, Nasim, Gerhäuser, Clarissa, Fletcher, Olivia, Swerdlow, Anthony J., Ko, Yon-Dschun, Brauch, Hiltrud, Brüning, Thomas, Hamann, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596937/
https://www.ncbi.nlm.nih.gov/pubmed/34789319
http://dx.doi.org/10.1186/s13148-021-01196-1
_version_ 1784600500495187968
author Manoochehri, Mehdi
Hielscher, Thomas
Borhani, Nasim
Gerhäuser, Clarissa
Fletcher, Olivia
Swerdlow, Anthony J.
Ko, Yon-Dschun
Brauch, Hiltrud
Brüning, Thomas
Hamann, Ute
author_facet Manoochehri, Mehdi
Hielscher, Thomas
Borhani, Nasim
Gerhäuser, Clarissa
Fletcher, Olivia
Swerdlow, Anthony J.
Ko, Yon-Dschun
Brauch, Hiltrud
Brüning, Thomas
Hamann, Ute
author_sort Manoochehri, Mehdi
collection PubMed
description BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHODS: Leukocyte subtype-specific unmethylated/methylated CpG sites were selected, and methylation levels at these sites were used as proxies for immune cell type proportions and mdNLR estimation in 231 TNBC cases and 231 age-matched controls. Data were validated using the Houseman deconvolution method. Additionally, the natural killer (NK) cell ratio was measured in a prospective sample set of 146 TNBC cases and 146 age-matched controls. RESULTS: The mdNLRs were higher in TNBC cases compared with controls and associated with TNBC (odds ratio (OR) range (2.66–4.29), all P(adj.) < 1e−04). A higher neutrophil ratio and lower ratios of NK cells, CD4 + T cells, CD8 + T cells, monocytes, and B cells were associated with TNBC. The strongest association was observed with decreased NK cell ratio (OR range (1.28–1.42), all P(adj.) < 1e−04). The NK cell ratio was also significantly lower in pre-diagnostic samples of TNBC cases compared with controls (P = 0.019). CONCLUSION: This immunomethylomic study shows that a shift in the ratios/proportions of leukocyte subtypes is associated with TNBC, with decreased NK cell showing the strongest association. These findings improve our knowledge of the role of the immune system in TNBC and point to the possibility of using NK cell level as a non-invasive molecular marker for TNBC risk assessment, early detection, and prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01196-1.
format Online
Article
Text
id pubmed-8596937
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85969372021-11-17 Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients Manoochehri, Mehdi Hielscher, Thomas Borhani, Nasim Gerhäuser, Clarissa Fletcher, Olivia Swerdlow, Anthony J. Ko, Yon-Dschun Brauch, Hiltrud Brüning, Thomas Hamann, Ute Clin Epigenetics Research BACKGROUND: A shift in the proportions of blood immune cells is a hallmark of cancer development. Here, we investigated whether methylation-derived immune cell type ratios and methylation-derived neutrophil-to-lymphocyte ratios (mdNLRs) are associated with triple-negative breast cancer (TNBC). METHODS: Leukocyte subtype-specific unmethylated/methylated CpG sites were selected, and methylation levels at these sites were used as proxies for immune cell type proportions and mdNLR estimation in 231 TNBC cases and 231 age-matched controls. Data were validated using the Houseman deconvolution method. Additionally, the natural killer (NK) cell ratio was measured in a prospective sample set of 146 TNBC cases and 146 age-matched controls. RESULTS: The mdNLRs were higher in TNBC cases compared with controls and associated with TNBC (odds ratio (OR) range (2.66–4.29), all P(adj.) < 1e−04). A higher neutrophil ratio and lower ratios of NK cells, CD4 + T cells, CD8 + T cells, monocytes, and B cells were associated with TNBC. The strongest association was observed with decreased NK cell ratio (OR range (1.28–1.42), all P(adj.) < 1e−04). The NK cell ratio was also significantly lower in pre-diagnostic samples of TNBC cases compared with controls (P = 0.019). CONCLUSION: This immunomethylomic study shows that a shift in the ratios/proportions of leukocyte subtypes is associated with TNBC, with decreased NK cell showing the strongest association. These findings improve our knowledge of the role of the immune system in TNBC and point to the possibility of using NK cell level as a non-invasive molecular marker for TNBC risk assessment, early detection, and prevention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-021-01196-1. BioMed Central 2021-11-17 /pmc/articles/PMC8596937/ /pubmed/34789319 http://dx.doi.org/10.1186/s13148-021-01196-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Manoochehri, Mehdi
Hielscher, Thomas
Borhani, Nasim
Gerhäuser, Clarissa
Fletcher, Olivia
Swerdlow, Anthony J.
Ko, Yon-Dschun
Brauch, Hiltrud
Brüning, Thomas
Hamann, Ute
Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title_full Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title_fullStr Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title_full_unstemmed Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title_short Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
title_sort epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596937/
https://www.ncbi.nlm.nih.gov/pubmed/34789319
http://dx.doi.org/10.1186/s13148-021-01196-1
work_keys_str_mv AT manoochehrimehdi epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT hielscherthomas epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT borhaninasim epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT gerhauserclarissa epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT fletcherolivia epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT swerdlowanthonyj epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT koyondschun epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT brauchhiltrud epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT bruningthomas epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients
AT hamannute epigeneticquantificationofcirculatingimmunecellsinperipheralbloodoftriplenegativebreastcancerpatients